专栏名称: 毕凯今选
由毕凯医药为您每周跟踪PUBMED十大瘤种最新前沿进展,编译制作,每日分享推送,希望我们的一点点绵薄之力,能为临床助力,做医生的朋友,做患者的帮助!
目录
相关文章推荐
哔哩哔哩  ·  哔哩哔哩视频号招实习生了! ·  14 小时前  
练瑜伽  ·  崩塌了……果然还是轮到她了 ·  18 小时前  
時間的玩家TimeIsArt  ·  每日临在 | 2025.02.21 ·  3 天前  
時間的玩家TimeIsArt  ·  每日临在 | 2025.02.21 ·  3 天前  
哔哩哔哩  ·  五毛特效拍哪吒,我的笑点和泪点在打架 ·  3 天前  
51好读  ›  专栏  ›  毕凯今选

【其他高分选 071】

毕凯今选  · 公众号  ·  · 2024-10-17 10:33

正文

BC

PMID: 39394640

IF:16.1

A Metal Chelation Therapy to Effectively Eliminate Breast Cancer and Intratumor Bacteria While Suppressing Tumor Metastasis by Copper Depletion and Zinc Ions Surge


SCI:Angew Chem Int Ed Engl

PMID:39395150

IF:15.8

Mechanotransduction-Piloted Whole-Cell Vaccines for Spatiotemporal Modulation of Postoperative Antitumor Immunity


SCI:ACS Nano

PMID:39393355

IF:48.8

Lactylation in cancer: Current understanding and challenges


SCI:Cancer Cell

PMID:39396338

IF:98.4

Progress in breast cancer management


SCI:Lancet

PMID:39401104

IF:15.8

Cold Exposure Therapy Sensitizes Nanodrug-Mediated Radioimmunotherapy of Breast Cancer


SCI:ACS Nano

PMID:39400947

IF:16.1

A Mechanical Immune Checkpoint Inhibitor Stiffens Tumor Cells to Potentiate Antitumor Immunity


SCI:Angew Chem Int Ed Engl

PMID:39400520

IF:10

Linking Metastatic Potential and Viscoelastic Properties of Breast Cancer Spheroids via Dynamic Compression and Relaxation in Microfluidics


SCI:Adv Healthc Mater

PMID:39402211

IF:13.7

127aa encoded by circSpdyA promotes FA synthesis and NK cell repression in breast cancers


SCI:Cell Death Differ

PMID:39402990

IF:12.5

Breast Cancer Disseminated Tumor Cells: Do They Stay and Fight or Run and Hide?


SCI:Cancer Res

PMID:39405827

IF:12.8

Mitochondrial-uncoupling nanomedicine for self-heating and immunometabolism regulation in cancer cells


SCI:Biomaterials

PMID:39412770

IF:63.1

Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems


SCI:JAMA



CRC

PMID:39395539

IF:56.7

Optimising Treatment Strategies in Metastatic Colorectal Cancer: Insights from CAIRO4


SCI:Ann Oncol



GC

PMID:39395400

IF:12.8

Dual HER2 inhibition: Is two better than one?


SCI:Med

PMID:39412948

IF:12.5

Ephrin A1 Stimulates CCL2 Secretion to Facilitate Pre-metastatic Niche Formation and Promote Gastric Cancer Liver Metastasis


SCI:Cancer Res



HCC

PMID:39393439

IF:26.8

CXCL12(+) Tumor-associated Endothelial Cells Promote Immune Resistance in Hepatocellular Carcinoma


SCI:J Hepatol

PMID:39396645

IF:26.8

MicroRNA-107 - a small RNA with a big impact on cytokinesis in hepatocellular carcinoma


SCI:J Hepatol

PMID:39402673

IF:10.6

Histidine phosphatase-ferroptosis crosstalk modulation for efficient hepatocellular carcinoma treatment


SCI:J Nanobiotechnology

PMID:39402741

IF:14.3

Oncofetal MCB1 Is a Functional Biomarker for HCC Personalized Therapy


SCI:Adv Sci (Weinh)

PMID:39405202

IF:14.3

Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1-Mediated Activation of NF-kappaB Signaling


SCI:Adv Sci (Weinh)

PMID:39406379

IF:14

Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma


SCI:Clin Mol Hepatol

PMID:39413161

IF:15.8

Intraoperative evaluation of tumor margins using a TROP2 near-infrared imaging probe to enable human breast-conserving surgery


SCI:Sci Transl Med



LC

PMID:39393945

IF:13.1

Channel plan: control of adaptive immune responses by pannexins


SCI:Trends Immunol

PMID:39395236

IF:10.3

RNA methyltransferase NSUN2-mediated m5C methylation promotes Cr(VI)-induced malignant transformation and lung cancer by accelerating metabolism reprogramming


SCI:Environ Int

PMID:39395838

IF:10.3

Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events


SCI:J Immunother Cancer

PMID:39395538

IF:56.7

Time to rethink platinum choices in the era of immunotherapy in lung cancer


SCI:Ann Oncol

PMID:39395537

IF:56.7

Inoperable Stage III EGFR Mutant Non-Small Cell Lung Cancer: time for drug first, local later?


SCI:Ann Oncol

PMID: 39396756

IF:56.7

PFS, OS or toxicity: What is the most important factor in the treatment of EGFR-mutated lung cancer


SCI:Ann Oncol

PMID: 39401431

IF:14.3

Dual-Activatable Nano-Immunomodulator for NIR-II Fluorescence Imaging-Guided Precision Cancer Photodynamic Immunotherapy


SCI:Adv Sci (Weinh)

PMID: 39405702

IF:12.2

m(6)A RNA methyltransferase METTL16 induces Cr(VI) carcinogenesis and lung cancer development through glutamine biosynthesis and GLUL expression


SCI:J Hazard Mater

PMID: 39405736

IF:15.8

Comprehensive metabolomic analysis identifies key biomarkers and modulators of immunotherapy response in NSCLC patients


SCI:Drug Resist Updat

PMID: 39406280

IF:10.5

Targeted nanoliposomes of oncogenic protein degraders: Significant inhibition of tumor in lung-cancer bearing mice


SCI:J Control Release

PMID: 39407016

IF:36.1

Interpretable spatially aware dimension reduction of spatial transcriptomics with STAMP


SCI:Nat Methods



PC







请到「今天看啥」查看全文